DETHACDA: A Dual-View Edge and Topology Hybrid Attention Model for CircRNA-Disease Associations Prediction

Insights

A new model, DETHACDA, accurately predicts circular RNA (circRNA) and disease associations by analyzing network topology and semantic information. This computational approach offers a faster, more precise alternative to traditional experimental methods for identifying therapeutic targets.

Area of Science:

  • Computational biology
  • Genomics
  • Bioinformatics

Background:

  • Circular RNAs (circRNAs) play roles in complex diseases and are potential therapeutic targets.
  • Experimental identification of disease-associated circRNAs is slow and resource-intensive.
  • Existing computational models for circRNA-disease association often overlook crucial semantic information.

Purpose of the Study:

  • To develop an intelligent and precise computational model for predicting circRNA-disease associations.
  • To improve upon existing graph-based methods by incorporating both network topology and semantic features.
  • To identify novel circRNA-disease associations for therapeutic development.

Main Methods:

  • Proposed a Dual-view Edge and Topology Hybrid Attention model (DETHACDA).
  • Utilized a heterogeneous network to capture neighborhood topology and diverse semantics of circRNA and disease nodes.
  • Employed 5-fold cross-validation for performance evaluation.

Main Results:

  • DETHACDA achieved an Area Under the Receiver Operating Characteristic Curve (AUROC) of 0.9882 on the circRNADisease dataset.
  • The model significantly outperformed four state-of-the-art computational methods.
  • Demonstrated the effectiveness of integrating topological and semantic information for accurate prediction.

Conclusions:

  • DETHACDA provides a highly accurate and efficient method for predicting circRNA-disease associations.
  • The model's ability to capture complex network features enhances its predictive power.
  • This approach facilitates the identification of circRNAs as potential biomarkers and therapeutic targets for complex diseases.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
Genomics02:02

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
36.5K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.6K